Use of pulmonary artery catheters in advanced heart failure

Current Opinion in Cardiology

Volumn 22, Issue 3, 2007, Pages 220-224

  Shah, Monica R ^a   Miller, Leslie ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Clinical trials; Heart failure; Pulmonary artery catheter

Indexed keywords

CLINICAL ASSESSMENT; EVALUATION; HEART FAILURE; HOSPITALIZATION; HUMAN; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY ARTERY CATHETER; REVIEW;

CATHETERIZATION, SWAN-GANZ; CRITICAL ILLNESS; EVIDENCE-BASED MEDICINE; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 34147221773     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32810c00e1     Document Type: Review

References (12)

1. Shah MR, Hasselblad V, et al. Impact of the Pulmonary Artery Catheter in Critically Ill Patients: Meta-Analysis of Randomized Clinical Trials. JAMA 2005; 294:1664-1670.
2. Steimle AE, Stevenson LW, Chelimsky-Fallick C, et al. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation 1997; 96:1165-1172.
3. Stevenson LOW. Tailored therapy to hemodynamic goals for advanced heart failure. European Journal of Heart Failure 1999; 1:251-257.
4. Fonarow GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. Journal of the American College of Cardiology 1997; 30:725-732.
5. Johnson W, Lucas C, Stevenson LW, Creager MA. Effect of intensive therapy for heart failure on the vasodilator response to exercise. Journal of the American College of Cardiology 1999; 33:743-749.
6. Rosario LB, Stevenson LW, Solomon SD, et al. The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size. Journal of the American College of Cardiology 1998; 32:1819-1824.
7. Zannad F, Briancon S, Juilliere Y, et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidemiologie de l'Insuffisance Cardiaque Avancée en Lorraine. Journal of the American College of Cardiology 1999; 33:734-742.
8. Fonarow GC, Chelimsky-Fallick C, Stevenson LW, et al. Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure. JACC 1992; 18:842-850.
9. Binanay C, Califf RM, Hasselblad V, et al., ESCAPE Investigators and ESCAPE Study Coordinators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 2005; 294:1625-1633.
10. Shah MR, O'Connor CM, Sopko G, et al. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale. American Heart Journal 2001; 141:528-535.
11. Hunt SA, Abraham WT, Chin MH, et al. American College of Cardiology. American Heart Association Task Force on Practice Guidelines. American College of Chest Physicians. International Society for Heart and Lung Transplantation. Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005; 112:e154-e235.
12. Heart Failure Society of America: Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 2006, 12:10-38.